Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer
Автор: OncLive
Загружено: 2015-07-29
Просмотров: 321
Описание: Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplantation, Department of Medicine, medical oncologist, University of Minnesota, discusses the research that led to the FDA approval of neoadjuvant pertuzumab as part of a combination regimen for patients with HER2-positive breast cancer.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: